Distinguished in Dementia

Christine A. Von Arnim

Robert Koch Str. 42a, 
Goettingen, NI, DE 
Distinguished in Dementia
Robert Koch Str. 42a, 
Goettingen, NI, DE 
OverviewLocationsClinical Research

Overview

Christine Von Arnim practices in Goettingen, Germany. Ms. Von Arnim is rated as a Distinguished expert by MediFind in the treatment of Dementia. Her top areas of expertise are Dementia, Alzheimer's Disease, Delirium, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Thrombectomy.

Her clinical research consists of co-authoring 146 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 94 articles and participated in 2 clinical trials in the study of Dementia.

Gender
Female

Locations

Robert Koch Str. 42a, Goettingen, NI 37075, Germany
Other Locations
Robert Koch Str. 40, Goettingen, NI 37075, Germany
Albert Einstein Allee 47, Ulm, BW 89081, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Study, Followed by an Open-Label Extension, to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of Intrathecally Administered ISIS 814907 in Patients With Mild Alzheimer's Disease
A Randomized, Double-Blind, Placebo-Controlled Study, Followed by an Open-Label Extension, to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of Intrathecally Administered ISIS 814907 in Patients With Mild Alzheimer's Disease
Enrollment Status: Completed
Publish Date: April 08, 2025
Intervention Type: Drug, Other
Study Drug: IONIS MAPTRx
Study Phase: Phase 1
Randomized Controlled Trial of Simvastatin in Amnestic MCI Patients
Randomized Controlled Trial of Simvastatin in Amnestic MCI Patients
Enrollment Status: Unknown
Publish Date: January 27, 2020
Intervention Type: Drug
Study Drug: Simvastatin
Study Phase: Phase 4
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
Enrollment Status: Terminated
Publish Date: December 03, 2019
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trials

146 Total Publications

Frailty's influence on older stroke patients: Neurological outcome and mortality after endovascular treatment in stroke: A national German stroke registry analysis.
Frailty's influence on older stroke patients: Neurological outcome and mortality after endovascular treatment in stroke: A national German stroke registry analysis.
Journal: European stroke journal
Published: June 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Von Arnim's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile